Neel Sharma1, Khek Yu Ho1. 1. Division of Gastroenterology and Hepatology, National University Hospital, Singapore.
Abstract
BACKGROUND: Gastro-oesophageal reflux disease (GORD) is a common global phenomenon. It is associated with the backflow of gastric contents proximally, typically due to transient relaxations of the lower oesophageal sphincter. Various factors contribute to GORD, including obesity, smoking, alcohol and pregnancy. The primary concern of GORD is its association with the development over time of Barrett's oesophagus and, ultimately, oesophageal adenocarcinoma. SUMMARY: This review focuses on the various medical interventions that are useful in the treatment of GORD. KEY MESSAGES: Various lifestyle interventions such as weight loss and smoking cessation are useful in the treatment of GORD. Medical therapy relies on the use of acid suppressants such as proton pump inhibitors and histamine H2 receptor antagonists.
BACKGROUND: Gastro-oesophageal reflux disease (GORD) is a common global phenomenon. It is associated with the backflow of gastric contents proximally, typically due to transient relaxations of the lower oesophageal sphincter. Various factors contribute to GORD, including obesity, smoking, alcohol and pregnancy. The primary concern of GORD is its association with the development over time of Barrett's oesophagus and, ultimately, oesophageal adenocarcinoma. SUMMARY: This review focuses on the various medical interventions that are useful in the treatment of GORD. KEY MESSAGES: Various lifestyle interventions such as weight loss and smoking cessation are useful in the treatment of GORD. Medical therapy relies on the use of acid suppressants such as proton pump inhibitors and histamine H2 receptor antagonists.
Authors: Brian C Jacobson; Samuel C Somers; Charles S Fuchs; Ciarán P Kelly; Carlos A Camargo Journal: N Engl J Med Date: 2006-06-01 Impact factor: 91.245
Authors: T Lind; T Havelund; L Lundell; H Glise; K Lauritsen; S A Pedersen; O Anker-Hansen; A Stubberöd; G Eriksson; R Carlsson; O Junghard Journal: Aliment Pharmacol Ther Date: 1999-07 Impact factor: 8.171
Authors: P Sharma; N J Shaheen; M C Perez; B L Pilmer; M Lee; S N Atkinson; D Peura Journal: Aliment Pharmacol Ther Date: 2009-04-01 Impact factor: 8.171
Authors: S Vigneri; R Termini; G Leandro; S Badalamenti; M Pantalena; V Savarino; F Di Mario; G Battaglia; G S Mela; A Pilotto Journal: N Engl J Med Date: 1995-10-26 Impact factor: 91.245